How are clinical operations leaders making strategic technology investments in 2021 and beyond?
This report provides insights from more than 200 respondents to the annual Florence State of the Industry Survey, from dozens of stakeholders who are members of the Florence Executive Advisory Board, and more than 8,500 study sites and more than 8,000 sponsors using Florence.
COVID-19 disrupted clinical trial operations in 2020 and mandated that leaders mitigate physical site access challenges with technology.
Leaders should do three things as they prepare their strategic plans for 2021:
- Reflect on 2020 and analyze how COVID-19 exposed inefficient clinical operations processes.
- Understand the clinical operations technology trends that are concrete enough to begin investing in 2021.
- Recognize the risks to be identified and mitigated in 2021.
- Prepare yourself for changes coming to the clinical operations landscape over the next three or more years.
In this Report you’ll learn:
- How COVID-19 impacted site and sponsor technology plans.
- Why remote site access is now a requirement for clinical operations.
- Where clinical operations will be investing in 2021.
- How to avoid failures when selecting technology.
- What’s on the horizon for clinical trial technology in 2023 and beyond.
- What steps you need to be taking next year to take part in the new clinical operations model.